During the second day of the American Academy of Dermatology’s 2022 annual meeting there were opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases. The sessions also included some late-breaking sessions with intriguing study results on dupilumab’s impact on COVID-19 and how new tools such as test strips may have implications for dermatology practice.

Click on the image above to view selected highlights from our team of analysts.

During the second day of the American Academy of Dermatology’s 2022 annual meeting there were opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases. The sessions also included some late-breaking sessions with intriguing study results on dupilumab’s impact on COVID-19 and how new tools such as test strips may have implications for dermatology practice.



Click on the image above to view selected highlights from our team of analysts.

During the second day of the American Academy of Dermatology’s 2022 annual meeting there were opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases. The sessions also included some late-breaking sessions with intriguing study results on dupilumab’s impact on COVID-19 and how new tools such as test strips may have implications for dermatology practice.



Click on the image above to view selected highlights from our team of analysts.

During the second day of the American Academy of Dermatology’s 2022 annual meeting there were opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases. The sessions also included some late-breaking sessions with intriguing study results on dupilumab’s impact on COVID-19 and how new tools such as test strips may have implications for dermatology practice.



Click on the image above to view selected highlights from our team of analysts.

During the second day of the American Academy of Dermatology’s 2022 annual meeting there were opportunities for attendees to learn about the latest advancements in clinical and cosmetic dermatology, including new and emerging treatments for common skin conditions and new tools that dermatologists can use to better diagnose and follow patients with skin diseases. The sessions also included some late-breaking sessions with intriguing study results on dupilumab’s impact on COVID-19 and how new tools such as test strips may have implications for dermatology practice.



Click on the image above to view selected highlights from our team of analysts.